Prosecution Insights
Last updated: November 15, 2026

Quantum-Si Incorporated

Technology area: Biotechnology & Pharmaceuticals

7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Analysis

Quantum-Si Incorporated has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 7 distinct examiners and 7 distinct art units, indicating complete dispersion across the active examination workload. No examiner or art-unit concentration is shown.

EIX, EMILY FAY is the busiest examiner, with 1 pending matter. That assignment is consistent with the broader distribution, so counsel should avoid relying on a single examiner strategy for the portfolio.

Portfolio management should emphasize matter-level deadlines, art-unit-specific technical positioning, and consistency checks across claim drafting. Similar subject matter may still require different responses because the available data does not identify common rejections or shared procedural histories.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

7
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (57%)
3
Medium (43%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (43%)
§103 only1 (14%)
Double-patenting + other2 (29%)
Multi-statute (no §101)1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
14% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
EIX, EMILY FAY 1 45.9% +73.9%
VARADARAJ, ARCHANA 1 57.1% +42.9%
PHAM, KHAI QUYNH TIEN 1 0.0% +0.0%
CROW, ROBERT THOMAS 1 41.4% +32.7%
JORDAN, ANDREW 1 44.4% +17.3%
GRAY, JESSICA 1 0.0% +0.0%
KRIANGCHAIVECH, KETTIP 1 18.6% +27.9%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18335963 METHODS AND COMPOSITIONS FOR PROTEIN FINGERPRINTING PHAM, KHAI QUYNH TIEN 12d
18365185 COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS VARADARAJ, ARCHANA —
17300940 Molecular Barcode Analysis by Single-Molecule Kinetics GRAY, JESSICA —
16686028 METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING KRIANGCHAIVECH, KETTIP —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17555323 OPTICAL REJECTION PHOTONIC STRUCTURES JORDAN, ANDREW 66d overdue
18491719 POLYPEPTIDE CLEAVING REAGENTS AND USES THEREOF EIX, EMILY FAY —
18365185 COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS VARADARAJ, ARCHANA —
18188122 HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING CROW, ROBERT THOMAS —
16686028 METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING KRIANGCHAIVECH, KETTIP —

Top Art Units

Art UnitApps
1653 1
1658 1
1684 1
1683 1
2874 1
1682 1
1686 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18491719 POLYPEPTIDE CLEAVING REAGENTS AND USES THEREOF EIX, EMILY FAY 1653 §103§112DP Non-Final OA — Pending Oct 20, 2023
18365185 COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS VARADARAJ, ARCHANA 1658 §101§102§103§112DP Non-Final OA — Pending Aug 03, 2023
18335963 METHODS AND COMPOSITIONS FOR PROTEIN FINGERPRINTING PHAM, KHAI QUYNH TIEN 1684 §102§103 Non-Final OA 12d Pending Jun 15, 2023
18188122 HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING CROW, ROBERT THOMAS 1683 §102§103DP Non-Final OA — Pending Mar 22, 2023
17555323 OPTICAL REJECTION PHOTONIC STRUCTURES JORDAN, ANDREW 2874 §103 Final Rejection 66d overdue Pending Dec 17, 2021
17300940 Molecular Barcode Analysis by Single-Molecule Kinetics GRAY, JESSICA 1682 §101§103 Final Rejection — Pending Dec 15, 2021
16686028 METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING KRIANGCHAIVECH, KETTIP 1686 §101§103DP Final Rejection — Pending Nov 15, 2019

Managing Quantum-Si Incorporated's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Quantum-Si Incorporated have?

Quantum-Si Incorporated has 7 pending office actions as of November 2026, spread across 7 art units and 7 examiners.

Which USPTO examiner handles the most Quantum-Si Incorporated applications?

Emily Fay Eix has the most, with 1 of Quantum-Si Incorporated's pending office actions.

What technology area are Quantum-Si Incorporated's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month